Preparation and bioavailability of bupropion hydrochloride sustained-release pellets

Ling-ping CHEN,Wen-li L(U),Qi-neng PING
DOI: https://doi.org/10.3321/j.issn:1000-5048.2009.05.008
2009-01-01
Abstract:Aim: To prepare bupropion hydrochloride (BH) 24-hour sustained-release pellets and to determine its oral bioavailability in rats. Methods: BH 24-hour sustained-release pellets were prepared through the method of extrusion-spheronization and then were coated by ethyl cellulose-based aqueous disperse system using Mini-Glatt. And BH plasma concentrations in rats receiving administration of BH pellets or commercially available BH tablets were determined by HPLC. The pharmacokinetic parameters were estimated by Kinetica software. Results: The cumulative release percents of BH sustained-release pellets in 2, 12 and 24 h were 10%, 80% and 95%, respectively. The plasma concentration-time curves of BH sustained-release pellets and BH tablets in rats after oral administration were fitted to two-and one-compartment models, respectively. AUCs of BH sustained-release pellets and BH tablets were found to be (1523.79 ± 323.30) ng·h/mL and (1379.67 ± 253.61) ng·h/mL, respectively; c maxs were (163.80 ± 32.93) ng/mL and (451.91 ± 144.54) ng/mL, respectively; and t maxs were (4.67 ± 0.52) h and (0.5 ± 0) h respectively. The relative bioavailability of BH sustained-release pellets to commercial BH tablets was (110.46 ± 17.07) %. Conclusion: The prepared BH 24-hour sustained-release pellets are bioequivalent to the commercial BH tablets.
What problem does this paper attempt to address?